* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Management of Chronic Airflow Obstruction
Survey
Document related concepts
Transcript
Management of Chronic Airflow Obstruction J.R. Sheller, M.D. Allergy, Pulmonary & Critical Care Medicine Chronic Airflow Obstruction • Asthma • COPD – emphysema/chronic obstructive bronchitis • Bronchiectasis – cystic fibrosis • Obliterative bronchiolitis • 12.1 million adults ages 25 and older reported being diagnosed with COPD; 21 million asthmatics • Total estimated cost of COPD $32.1 billion, asthma was $13.8 • COPD is the fourth leading cause of death in the U.S. and is projected to be the third leading cause of death by the year 2020. • 5000 deaths/yr from asthma Spirometry Functional residual capacity 100 FEV1 (%) max 50 Disability Death 20 Time (yrs) 40 80 100 FEV1 (%) 50 Disability Death 20 Time (yrs) 40 80 Smoking Cessation • Counseling – Has patient thought about stopping? – Rehearse reasons to quit – Offer to help • Group therapy – quitting sessions Cancer Society, Heart Assoc., Lung Assoc. • Medications – Wellbutrin – Nicotine – Clonidine Bronchodilators • Beta2 adrenergic agonists – By metered dose inhaler – By nebulizer • Short acting – albuterol, terbutaline – rescue medicine • Long acting – salmeterol, formoterol – Not used for “rescue” Anticholinergics • Ipratropium • Tiatropium Work best in COPD Viral exacerbations of asthma in children Theophylline • Methylxanthines – adenosine antagonists, phosphodiesterase inhibitors, induces histone deactylase • Narrow therapeutic window • Not important in emergency • May help in difficult cases • Phosphodiesterase 4 inhibitor Antiinflammatory RX • • • • Can improve function Can improve symptoms Uncertain if it alters natural history May affect structural changes (remodeling) Inhaled Corticosteroids • Topically active • Delivered to the airway • First pass liver metabolism reduces systemic availability • Unknown mechanism of action Inhaled Corticosteroids • Theoretical: – suppression of adrenals – growth retardation in kids • Known: – oral thrush and vocal cord dysfunction – Increased cataracts – Increased loss of bone • Beclomethasone – 2 puffs QID • Triamcinalone – 2 inhalations TID • Fluticasone – 2 inhalations BID (3 strengths) • Flunisolide – 2 inhalations BID • Budesonide – 2 inhalations BID Convenient, cheap Leukotriene Modifiers • Zileuton – 5 Lipoxygenase inhibitor • Receptor antagonist – Zafirlukast 20mg BID – Montelukast 10mg QD COPD • • • • 72 year old smoker for 60yrs Cough, sputum production, dyspnea FEV1 33% predicted; DLCO 25% predicted Rhonchi, wheezes, pedal edema DX: Chronic obstructive bronchitis and emphysema http://www.goldcopd.com/ COPD Rx • • • • • Smoking cessation Inhaled ipratropium, beta agonist using MDI Long acting beta adrenergic - salmeterol Flu vaccine, pneumovax Antimicrobials for increased sputum (amoxicillin, doxycycline, macrolides, trimethoprim/sulfa) • Inhaled corticosteroids controversial • Avoid oral steroids • Calls with low grade fever, dyspnea, ankle edema • Admitted to hospital with SaO2 75% • Oxygen by nasal prongs • BiPAP (non invasive ventilation) • Systemic steroids – iv methylprednisolone, convert to oral (60mg prednisone) • Nebulized ipratropium/albuterol • Pneumovax, influenza vaccine Home Oxygen • SaO2 <89% (or pulmonary hypertension, Hct >55, CHF) • Should be used 24hrs day • After 6 weeks, recheck sats (50% of patients no longer need it) Home oxygen tethers patients, causing deconditioning Pulmonary rehab, activity are important • 35 year old female with episodic cough, wheezing, dyspnea after jogging • Childhood history of asthma • Atopic (hay fever) • Normal exam • FEV1 normal; FEV1/FVC reduced • Albuterol MDI prior to exercise • Medication works, but she uses it each day • Add inhaled steroids • Now awakening at night with cough • Add long acting beta agonist (salmeterol, formoterol; or combination, eg Advair, Symbicort) • Rehearse inhaler use, action plan • Allergy/Pulmonary consultation http://www.nhlbi.nih.gov/about/naepp/ • Still having problems with dyspnea, uses albuterol several times a day • GERD, Sinus disease • Increase inhaled steroids • Add leukotriene modifier Montelukast, zafirlukast – receptor blockers Zileuton – inhibitor of 5-lipoxygenase • Consider theophylline • Anti IgE (omalizumab) • Has symptoms of URI, using albuterol every 2hrs, not getting relief • ED Rx – Oxygen – Continuous albuterol – Intravenous methylprednisolone 125mg – Ipratropium – Mg may help those with most severe obstruction – Measure PEFR, FEV1, pulsus paradoxus – Admit in 2hrs if no improvement Risk of death in Asthma • • • • • Frequent hospitalizations Intubated for asthma Poor perception of airflow obstruction Frequent albuterol rescue medication use Psychosocial problems Treatment Scheme • Mild intermittent • Mild persistent • Moderate • Severe b-agonists + inhaled steroids salmeterol, more inhaled steroids, leukotriene modifiers theophylline, oral steroids, anti IgE